Aktis Oncology IPO 2026: Nasdaq Launch & Cancer Therapy Update
Aktis Oncology, Inc., a leading U.S.-based biotech company, is set to go public on the Nasdaq through its…
Aktis Oncology, Inc., a leading U.S.-based biotech company, is set to go public on the Nasdaq through its…